JACQUELYN KOEPP: Open Payments
NPI 1215491501 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 93 payments from 19 companies in 2025. Trend: 2023 $1,265 · 2024 $1,384 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $203 |
| Corium, LLC | 14 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $153 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Supernus Pharmaceuticals, Inc. | 5 | $94 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| Lilly USA, LLC | 2 | $44 |
| Tris Pharma Inc | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Amgen Inc. | 2 | $40 |
Products named: Azstarys, CAPLYTA, Qelbree, UBRELVY, VRAYLAR, REXULTI, Jornay PM, Dyanavel XR.
Industry payments across KY — which companies pay providers there.
